Topical Ruxolitinib in Chronic Hand Dermatitis

Summary

This is an investigator-initiated, proof of concept, open study to assess efficacy of a topical Ruxolitinib in subjects with Chronic Hand Dermatitis (CHD). The study will be conducted at the University of Rochester Medical center, Dermatology Department - Rochester, NY. Qualified and enrolled subjects (see Inclusion/Exclusion criteria) will be required to come to URMC Dermatology Clinic for at least five visits.

Timeline

Start

2022-07-11

Primary completion

2023-06-21

Completion

2024-12-31

Drugs

Indications